Portuguese Business Awards 2026

Sea4Us is a Portuguese biotechnology company developing first-in-class, marine-inspired, therapeutics, for diseases driven by aberrant neuronal activity. Its lead program, S072, is a novel non-opioid analgesic for severe chronic and acute pain, currently in Phase 1 clinical trials. Sea4Us combines a proprietary discovery platform, strong intellectual property, and international partnerships to address major unmet clinical needs in pain and neuroscience.